Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel
Cannabis Law Report
AUGUST 31, 2021
With this, Canonic has completed its end-to-end cannabis value chain in Israel , from seed to product. According to industry estimates, based on current growth rates, the Israeli market will reach approximately 250,000 patients by 2025.[4]. Full commercial product launch in Israel is expected in 2022. About Canonic Ltd.:
Let's personalize your content